Pharma firms make a bold move against Trump, most Americans feel it
Pharmaceutical giants are not simply lining up behind President Donald Trump’s drug agenda, they are trying to bend it. The headline deals that look like cooperation on prices and tariffs also function as a strategic pushback, limiting how far the White House can go while reshaping who pays and who benefits. Most Americans feel the…